These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37589744)

  • 1. AUF1-induced circular RNA hsa_circ_0010467 promotes platinum resistance of ovarian cancer through miR-637/LIF/STAT3 axis.
    Wu Y; Xu M; Feng Z; Wu H; Wu J; Ha X; Wu Y; Chen S; Xu F; Wen H; Li S; Wu X
    Cell Mol Life Sci; 2023 Aug; 80(9):256. PubMed ID: 37589744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0078607 increases platinum drug sensitivity via miR-196b-5p/GAS7 axis in ovarian cancer.
    Dai C; Dai SY; Gao Y; Yan T; Zhou QY; Liu SJ; Liu X; Deng DN; Wang DH; Qin QF; Zi D
    Epigenetics; 2023 Dec; 18(1):2175565. PubMed ID: 36908025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M6A-mediated hsa_circ_0061179 inhibits DNA damage in ovarian cancer cells via miR-143-3p/TIMELESS.
    Zhang Y; Wu Y; Shi X; Ding H; Zhou Y; Chen H; Shen F; Chen Y; Zhou J; Zhou D; Wang J
    Mol Carcinog; 2024 Aug; 63(8):1542-1558. PubMed ID: 38751015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa_circ_0013561 promotes epithelial-mesenchymal transition and tumor progression by regulating ANXA2 via miR-23b-3p in ovarian cancer.
    Lv J; Zhang Y; Yang M; Qiao L; Wang H; Jiang H; Fu M; Qin J; Xu S
    Cancer Gene Ther; 2024 Jan; 31(1):108-118. PubMed ID: 38102461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating PTEN expression.
    Han Y; Zheng Y; You J; Han Y; Lu X; Wang X; Shi C; Zhu W
    Clin Transl Oncol; 2023 Oct; 25(10):2901-2910. PubMed ID: 37000289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination.
    Zhu Y; Liang L; Zhao Y; Li J; Zeng J; Yuan Y; Li N; Wu L
    J Nanobiotechnology; 2024 Jan; 22(1):35. PubMed ID: 38243224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0001741 Suppresses Ovarian Cancer Cell Proliferations Through Adsorption of miR-188-5p and Promotion of FOXN2 Expression.
    Wang H; Liang C; Lin J; Dong Y; Wang Y; Xia L
    Mol Biotechnol; 2024 Jun; 66(6):1477-1483. PubMed ID: 37318741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hsa_circ_0003176 Suppresses the Progression of Non-Small-Cell Lung Cancer via Regulating miR-182-5p/RBM5 Axis.
    Yang F; Pei Y; Xu W; Rong L
    Dis Markers; 2022; 2022():8402116. PubMed ID: 36193508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR/MAPK signaling pathway.
    Ji J; Li C; Wang J; Wang L; Huang H; Li Y; Fang J
    Cell Cycle; 2022 Apr; 21(7):685-696. PubMed ID: 35113003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    Cheng J; Zhang R; Yan M; Li Y
    BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA (hsa_circ_0051240) promotes cell proliferation, migration and invasion in ovarian cancer through miR-637/KLK4 axis.
    Zhang M; Xia B; Xu Y; Zhang Y; Xu J; Lou G
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1224-1233. PubMed ID: 30945557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis.
    Liu T; Yuan L; Zou X
    J Ovarian Res; 2022 Aug; 15(1):95. PubMed ID: 35965327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hsa_circ_0006916 promotes hepatocellular carcinoma progression by activating the miR-337-3p/STAT3 axis.
    Zhou XY; Yang H; Bai YQ; Li XL; Han SY; Zhou BX
    Cell Mol Biol Lett; 2020 Nov; 25(1):47. PubMed ID: 33292166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of hsa_circ_0007874 suppresses the progression of ovarian cancer by regulating the miR-760/SOCS3 pathway.
    Li L; Yu P; Zhang P; Wu H; Chen Q; Li S; Wang Y
    Cancer Med; 2020 Apr; 9(7):2491-2499. PubMed ID: 32023009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network.
    Huang H; Yan L; Zhong J; Hong L; Zhang N; Luo X
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):275-286. PubMed ID: 35196944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
    Jin M; Lu S; Wu Y; Yang C; Shi C; Wang Y; Huang G
    J Exp Clin Cancer Res; 2020 Sep; 39(1):186. PubMed ID: 32928266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis.
    You J; Han Y; Qiao H; Han Y; Lu X; Lu Y; Wang X; Kai H; Zheng Y
    Aging (Albany NY); 2022 Jun; 14(11):4699-4713. PubMed ID: 35687899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0026123 promotes cisplatin resistance and progression of ovarian cancer by upregulating RAB1A through sequestering miR-543.
    Wei L; He W; Zhao H; Zhao P
    Anticancer Drugs; 2022 Nov; 33(10):1069-1080. PubMed ID: 36255068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
    Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
    J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.
    Sheng H; Wang X
    Anticancer Drugs; 2023 Feb; 34(2):214-226. PubMed ID: 36730637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.